Mediar Therapeutics: Under Deal, Eligible to Get High-Single to Low-Double Digit Royalty Payments & Net Sales Milestones Based on Future Product Sales
Mediar Therapeutics:根據協議,有資格獲得基於未來產品銷售的高單位到低雙位的版稅支付及淨銷售里程碑。
Mediar Therapeutics: Under Deal, Eligible to Get High-Single to Low-Double Digit Royalty Payments & Net Sales Milestones Based on Future Product Sales
Mediar Therapeutics:根據協議,有資格獲得基於未來產品銷售的高單位到低雙位的版稅支付及淨銷售里程碑。
使用瀏覽器的分享功能,分享給你的好友吧